The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy

Published:2015-08-28 Issue:10 Volume:4 Page:e1042198
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

De Wolf Katrien¹,Vermaelen Karim²,De Meerleer Gert¹,Lambrecht Bart N³⁴⁵⁶,Ost Piet¹

Affiliation:

1. Department of Radiation Oncology and Experimental Cancer Research; Ghent University Hospital; Ghent, Belgium

2. Tumor Immunology Laboratory; Department of Pulmonary Medicine; Ghent University Hospital; Ghent, Belgium

3. Unit Immunoregulation and Mucosal Immunology; VIB Inflammation Research Center; Ghent, Belgium

4. GROUP-ID Consortium; Ghent University and University Hospital; Ghent, Belgium

5. Department of Respiratory Medicine; Ghent University; Ghent, Belgium

6. Department of Pulmonary Medicine; Erasmus MC; Rotterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1042198

Reference118 articles.

1. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine

2. Surgery for Metastases of Renal Cell Carcinoma

3. EAU Guidelines on Renal Cell Carcinoma: The 2010 Update

4. Targeted therapy for advanced renal cell carcinoma

5. Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group;Frontiers in Oncology;2024-05-24

2. Concurrent Stereotactic Ablative Radiotherapy and Antiangiogenic Targeted Agents: Redefining the Therapeutic Strategy;European Urology Oncology;2023-04

3. Ionizing Radiation Drives Key Regulators of Antigen Presentation and a Global Expansion of the Immunopeptidome;Molecular & Cellular Proteomics;2022-11

4. Effectiveness of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with brain metastases from renal cell carcinoma: inverse probability of treatment weighting using propensity scores;Journal of Neurosurgery;2022-10-01

5. Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical Applications;Anticancer Research;2022-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3